GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Net Cash per Share

Mizuho Medy Co (TSE:4595) Net Cash per Share : 円689.91 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Mizuho Medy Co's Net Cash per Share for the quarter that ended in Mar. 2024 was 円689.91.

The historical rank and industry rank for Mizuho Medy Co's Net Cash per Share or its related term are showing as below:

TSE:4595' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.75   Med: 7.03   Max: 222.44
Current: 4.89

During the past 10 years, the highest Price-to-Net-Cash Ratio of Mizuho Medy Co was 222.44. The lowest was 2.75. And the median was 7.03.

TSE:4595's Price-to-Net-Cash is ranked better than
63.18% of 258 companies
in the Drug Manufacturers industry
Industry Median: 6.855 vs TSE:4595: 4.89

Mizuho Medy Co Net Cash per Share Historical Data

The historical data trend for Mizuho Medy Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Net Cash per Share Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -251.52 -232.43 17.03 407.66 720.51

Mizuho Medy Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 568.85 768.22 622.59 720.51 689.91

Competitive Comparison of Mizuho Medy Co's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's Price-to-Net-Cash falls into.



Mizuho Medy Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Mizuho Medy Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(10134.764-3272.35-0)/9.5244
=720.51

Mizuho Medy Co's Net Cash per Share for the quarter that ended in Mar. 2024 is calculated as

Net Cash per Share (Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(9790-3219-0)/9.52437
=689.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co  (TSE:4595) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Mizuho Medy Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co (TSE:4595) Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines